Follow
Daniel Bottomly
Daniel Bottomly
Verified email at ohsu.edu
Title
Cited by
Cited by
Year
Functional genomic landscape of acute myeloid leukaemia
JW Tyner, CE Tognon, D Bottomly, B Wilmot, SE Kurtz, SL Savage, ...
Nature 562 (7728), 526-531, 2018
10482018
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML
JE Maxson, J Gotlib, DA Pollyea, AG Fleischman, A Agarwal, CA Eide, ...
New England Journal of Medicine 368 (19), 1781-1790, 2013
6072013
Evaluating gene expression in C57BL/6J and DBA/2J mouse striatum using RNA-Seq and microarrays
D Bottomly, NAR Walter, JE Hunter, P Darakjian, S Kawane, KJ Buck, ...
PloS one 6 (3), e17820, 2011
2692011
Modeling host genetic regulation of influenza pathogenesis in the collaborative cross
MT Ferris, DL Aylor, D Bottomly, AC Whitmore, LD Aicher, TA Bell, ...
PLoS pathogens 9 (2), e1003196, 2013
2162013
Identification of β-catenin binding regions in colon cancer cells using ChIP-Seq
D Bottomly, SL Kyler, SK McWeeney, GS Yochum
Nucleic acids research 38 (17), 5735-5745, 2010
1832010
Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms
H Zhang, S Savage, AR Schultz, D Bottomly, L White, E Segerdell, ...
Nature communications 10 (1), 244, 2019
1502019
Utilizing RNA-Seq data for de novo coexpression network inference
OD Iancu, S Kawane, D Bottomly, R Searles, R Hitzemann, S McWeeney
Bioinformatics 28 (12), 1592-1597, 2012
1452012
Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation
L Gao, J Schwartzman, A Gibbs, R Lisac, R Kleinschmidt, B Wilmot, ...
PloS one 8 (5), e63563, 2013
1442013
Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia
H Zhang, Y Nakauchi, T Köhnke, M Stafford, D Bottomly, R Thomas, ...
Nature cancer 1 (8), 826-839, 2020
1252020
Genes, behavior and next‐generation RNA sequencing
R Hitzemann, D Bottomly, P Darakjian, N Walter, O Iancu, R Searles, ...
Genes, Brain and Behavior 12 (1), 1-12, 2013
1032013
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia
D Bottomly, N Long, AR Schultz, SE Kurtz, CE Tognon, K Johnson, M Abel, ...
Cancer cell 40 (8), 850-864. e9, 2022
1022022
Expression quantitative trait Loci for extreme host response to influenza a in pre-collaborative cross mice
D Bottomly, MT Ferris, LD Aicher, E Rosenzweig, A Whitmore, DL Aylor, ...
G3: Genes| Genomes| Genetics 2 (2), 213-221, 2012
952012
The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance
SK Joshi, T Nechiporuk, D Bottomly, PD Piehowski, JA Reisz, ...
Cancer cell 39 (7), 999-1014. e8, 2021
712021
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis
H Zhang, B Wilmot, D Bottomly, KHT Dao, E Stevens, CA Eide, V Khanna, ...
Blood, The Journal of the American Society of Hematology 134 (11), 867-879, 2019
702019
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML
F Yang, N Long, T Anekpuritanang, D Bottomly, JC Savage, T Lee, ...
Blood, The Journal of the American Society of Hematology 139 (8), 1208-1221, 2022
572022
Identification and characterization of tyrosine kinase nonreceptor 2 mutations in leukemia through integration of kinase inhibitor screening and genomic analysis
JE Maxson, ML Abel, J Wang, X Deng, S Reckel, SB Luty, H Sun, ...
Cancer research 76 (1), 127-138, 2016
402016
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia
CA Lachowiez, N Long, J Saultz, A Gandhi, LF Newell, B Hayes-Lattin, ...
Blood Advances 7 (9), 1899-1909, 2023
322023
High throughput sequencing in mice: a platform comparison identifies a preponderance of cryptic SNPs
NAR Walter, D Bottomly, T Laderas, MA Mooney, P Darakjian, RP Searles, ...
BMC genomics 10, 1-11, 2009
282009
Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms
SK Joshi, K Qian, WH Bisson, K Watanabe-Smith, A Huang, D Bottomly, ...
Blood, The Journal of the American Society of Hematology 135 (24), 2159-2170, 2020
272020
Biomarkers predicting venetoclax sensitivity and strategies for venetoclax combination treatment
H Zhang, B Wilmot, D Bottomly, SE Kurtz, CA Eide, A Damnernsawad, ...
Blood 132, 175, 2018
242018
The system can't perform the operation now. Try again later.
Articles 1–20